These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 19571476)

  • 1. Children's toxicology from bench to bed--Drug-induced renal injury (1): The toxic effects of ARB/ACEI on fetal kidney development.
    Sekine T; Miura K; Takahashi K; Igarashi T
    J Toxicol Sci; 2009; 34 Suppl 2():SP245-50. PubMed ID: 19571476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No impact of hyperkalaemia with renin-angiotensin system blockades in maintenance haemodialysis patients.
    Han SW; Won YW; Yi JH; Kim HJ
    Nephrol Dial Transplant; 2007 Apr; 22(4):1150-5. PubMed ID: 17255126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of fetal and neonatal renal impairment by pharmacologic inhibition of angiotensin.
    Chevalier RL
    Curr Med Chem; 2012; 19(27):4572-80. PubMed ID: 22876894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Renin-Angiotensin Aldosterone System Inhibition on Serum Potassium Levels among Peritoneal Dialysis Patients.
    Ribeiro SC; Figueiredo AE; Barretti P; Pecoits-Filho R; de Moraes TP;
    Am J Nephrol; 2017; 46(2):150-155. PubMed ID: 28738355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analytical review of the evidence for renoprotection by renin-angiotensin-aldosterone system blockade in chronic kidney disease - a call for caution.
    Onuigbo MA
    Nephron Clin Pract; 2009; 113(2):c63-9, discussion c70. PubMed ID: 19602900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of calcium channels blockers and inhibitors of the renin-angiotensin system on renal outcomes and mortality in patients suffering from chronic kidney disease: systematic review and meta-analysis.
    Zhao HJ; Li Y; Liu SM; Sun XG; Li M; Hao Y; Cui LQ; Wang AH
    Ren Fail; 2016 Jul; 38(6):849-56. PubMed ID: 27055479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of angiotensin converting enzyme inhibitors and angiotensin receptor blockers in contrast-induced nephropathy.
    Zhou L; Duan S
    Kidney Blood Press Res; 2013; 38(2-3):165-71. PubMed ID: 24686005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognosis and outcome of pregnancies exposed to renin-angiotensin system blockers.
    Spaggiari E; Heidet L; Grange G; Guimiot F; Dreux S; Delezoide AL; ; Muller F
    Prenat Diagn; 2012 Nov; 32(11):1071-6. PubMed ID: 22903358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of renin-angiotensin-aldosterone system-blocking agents on the risk of contrast-induced acute kidney injury: a prospective study and meta-analysis.
    Peng F; Su J; Lin J; Niu W
    J Cardiovasc Pharmacol; 2015 Mar; 65(3):262-8. PubMed ID: 25502308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is there an embryopathy associated with first-trimester exposure to angiotensin-converting enzyme inhibitors and angiotensin receptor antagonists? A critical review of the evidence.
    Polifka JE
    Birth Defects Res A Clin Mol Teratol; 2012 Aug; 94(8):576-98. PubMed ID: 22807387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperkalemia associated with use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
    Raebel MA
    Cardiovasc Ther; 2012 Jun; 30(3):e156-66. PubMed ID: 21883995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of and risk factors for severe acute kidney injury in children with heart failure treated with renin-angiotensin system inhibitors.
    Terano C; Ishikura K; Miura M; Hamada R; Harada R; Sakai T; Hamasaki Y; Hataya H; Ando T; Honda M
    Eur J Pediatr; 2016 May; 175(5):631-7. PubMed ID: 26687571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. To RAS or not to RAS? The evidence for and cautions with renin-angiotensin system inhibition in patients with diabetic kidney disease.
    St Peter WL; Odum LE; Whaley-Connell AT
    Pharmacotherapy; 2013 May; 33(5):496-514. PubMed ID: 23576066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetics of congenital anomalies of the kidney and urinary tract.
    Song R; Yosypiv IV
    Pediatr Nephrol; 2011 Mar; 26(3):353-64. PubMed ID: 20798957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative effectiveness of angiotensin receptor blockers vs. angiotensin-converting enzyme inhibitors on cardiovascular outcomes in patients initiating peritoneal dialysis.
    Shen JI; Saxena AB; Montez-Rath ME; Leng L; Chang TI; Winkelmayer WC
    J Nephrol; 2017 Apr; 30(2):281-288. PubMed ID: 27485007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin-converting enzyme inhibitors (ACEIs), not angiotensin receptor blockers (ARBs), are preferred and effective mode of therapy in high cardiovascular risk patients.
    Vijan SG
    J Indian Med Assoc; 2009 Mar; 107(3):178-82. PubMed ID: 19810392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salt-losing nephrogenic diabetes insipidus caused by fetal exposure to angiotensin receptor blocker.
    Miura K; Sekine T; Iida A; Takahashi K; Igarashi T
    Pediatr Nephrol; 2009 Jun; 24(6):1235-8. PubMed ID: 19153776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on role of direct renin inhibitor in diabetic kidney disease.
    Dhakarwal P; Agrawal V; Kumar A; Goli KM; Agrawal V
    Ren Fail; 2014 Jul; 36(6):963-9. PubMed ID: 24678880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual blockade of the renin-angiotensin-aldosterone system with high-dose angiotensin-converting enzyme inhibitor for nephroprotection: an open, controlled, randomized study.
    Tylicki L; Renke M; Rutkowski P; Larczyński W; Aleksandrowicz E; Lysiak-Szydlowska W; Rutkowski B
    Scand J Urol Nephrol; 2008; 42(4):381-8. PubMed ID: 19230172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A nonpeptide, piperidine renin inhibitor provides renal and cardiac protection in double-transgenic mice expressing human renin and angiotensinogen genes.
    Major TC; Olszewski B; Rosebury W; Okerberg C; Carlson T; Ostroski R; Schroeder R; Kowala MC; Leadley R
    Cardiovasc Drugs Ther; 2008 Dec; 22(6):469-78. PubMed ID: 18679781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.